These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Reduction in the severity of myocardial infarction by sulfinpyrazone. Innes IR; Weisman H Am Heart J; 1981 Aug; 102(2):153-7. PubMed ID: 7258086 [TBL] [Abstract][Full Text] [Related]
34. Sulphinpyrazone, aspirin, and uric acid. Walter E; Staiger C Lancet; 1980 May; 1(8178):1131. PubMed ID: 6103456 [No Abstract] [Full Text] [Related]
35. Sulphinpyrazone (Anturan) after myocardial infarct. Watt M N Z Med J; 1979 Oct; 90(646):352. PubMed ID: 392352 [No Abstract] [Full Text] [Related]
36. Sulphinpyrazone in the prevention of cardiac death after myocardial infarction. S Afr Med J; 1980 Mar; 57(9):301-2. PubMed ID: 6986664 [No Abstract] [Full Text] [Related]
37. The anturane reinfarction trial. Sauerbruch T; Kaess H N Engl J Med; 1980 Jul; 303(1):49-50. PubMed ID: 6990266 [No Abstract] [Full Text] [Related]
38. In vivo platelet hyperactivity and factor VIII related antigen increase long after myocardial infarction. A controlled effect of sulfinpyrazone. Cortellaro M; Boschetti C; Beggi P; Polli EE Scand J Haematol; 1981 Feb; 26(2):106-14. PubMed ID: 6454960 [TBL] [Abstract][Full Text] [Related]
39. [The Anturan reinfarct study]. Sherry S Wien Med Wochenschr Suppl; 1980; 61():17-22. PubMed ID: 6930766 [No Abstract] [Full Text] [Related]
40. A randomized trial of aspirin and sulfinpyrazone in patients with threatened stroke. Results and methodologic issues. Gent M; Barnett HJ; Sackett DL; Taylor DW Circulation; 1980 Dec; 62(6 Pt 2):V97-105. PubMed ID: 7002357 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]